Patient Selection for Transplantation in the Myelodysplastic Syndromes

被引:6
作者
Cutler, Corey [1 ]
机构
[1] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA
关键词
Stem cell transplantation; Myelodysplastic syndromes; Allogeneic; STEM-CELL TRANSPLANTATION; COMORBIDITY INDEX; PROGNOSTIC IMPACT; UNRELATED DONORS; RISK; SURVIVAL; MDS; INTENSITY; RELEVANCE; LEUKEMIA;
D O I
10.1016/j.hoc.2010.02.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Allogeneic hematopoietic stem cell transplantation remains the only known curative procedure for the myelodysplastic syndromes (MDS). Because the median age at diagnosis for MDS is in the late seventh decade of life, despite the curative potential, transplantation is not undertaken routinely, and careful consideration must be made regarding the appropriateness of the transplant recipient. This article focuses on appropriate patient selection for transplantation for MDS.
引用
收藏
页码:469 / +
页数:9
相关论文
共 21 条
[1]   WHO classification and WPSS predict posttransplantation outcome in patients with myelodysplastic syndrome:: a study from the Gruppo Italiano Trapianto di Midollo Osseo (GITMO) [J].
Alessandrino, Emilio Paolo ;
Della Porta, Matteo Giovanni ;
Bacigalupo, Andrea ;
Van Lint, Maria Teresa ;
Falda, Michele ;
Onida, Francesco ;
Bernardi, Massimo ;
Iori, Anna Paola ;
Rambaldi, Alessandro ;
Cerretti, Raffaella ;
Marenco, Paola ;
Pioltelli, Pietro ;
Malcovati, Luca ;
Pascutto, Cristiana ;
Oneto, Rosi ;
Fanin, Renato ;
Bosi, Alberto ;
Levis, A. ;
Rambaldi, A. ;
Bandini, G. ;
Casini, M. ;
Rossi, G. ;
Angelucci, E. ;
Baronciani, D. ;
La Nasa, G. ;
Milone, G. ;
Mordini, N. ;
Guidi, S. ;
Bosi, A. ;
Bacigalupo, A. ;
Van Lint, M. T. ;
Corradini, P. ;
Milani, R. ;
Morra, E. ;
Marenco, P. ;
Deliliers, G. Lambretenghi ;
Onida, F. ;
Ciceri, F. ;
Bernardi, M. ;
Castagna, L. ;
Narni, F. ;
Pioltelli, P. ;
Selleri, Carmine ;
Scime, R. ;
Iannitto, E. ;
Musso, M. ;
Alessandrino, E. P. ;
Locatelli, F. ;
Martelli, F. ;
Visani, G. .
BLOOD, 2008, 112 (03) :895-902
[2]   Impact of conditioning regimen intensity on outcome of allogeneic hematopoietic cell transplantation for advanced acute myelogenous leukemia and myelodyspiastic syndrome [J].
Alyea, Edwin P. ;
Kim, Haesook T. ;
Ho, Vincent ;
Cutler, Corey ;
DeAngelo, Daniel J. ;
Stone, Richard ;
Ritz, Jerome ;
Antin, Joseph H. ;
Soiffer, Robert J. .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (10) :1047-1055
[3]   Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation [J].
Armand, Philippe ;
Kim, Haesook T. ;
Cutler, Corey S. ;
Ho, Vincent T. ;
Koreth, John ;
Alyea, Edwin P. ;
Soiffer, Robert J. ;
Antin, Joseph H. .
BLOOD, 2007, 109 (10) :4586-4588
[4]   A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes:: delayed transplantation for low-risk myelodysplasia is associated with improved outcome [J].
Cutler, CS ;
Lee, SJ ;
Greenberg, P ;
Deeg, HJ ;
Pérez, WS ;
Anasetti, C ;
Bolwell, BJ ;
Cairo, MS ;
Gale, RP ;
Klein, JP ;
Lazarus, HM ;
Liesveld, JL ;
McCarthy, PL ;
Milone, GA ;
Rizzo, JD ;
Schultz, KR ;
Trigg, ME ;
Keating, A ;
Weisdorf, DJ ;
Antin, JH ;
Horowitz, MM .
BLOOD, 2004, 104 (02) :579-585
[5]   Allogeneic stem cell transplantation for patients with refractory anaemia with matched related and unrelated donors: delay of the transplant is associated with inferior survival [J].
de Witte, Theo ;
Brand, Ronald ;
van Biezen, Anja ;
Mufti, Ghulam ;
Ruutu, Tapani ;
Finke, Juergen ;
von dem Borne, Peter ;
Vitek, Antonin ;
Delforge, Michel ;
Alessandrino, Paolo ;
Harlahakis, Nicolas ;
Russell, Nigel ;
Martino, Roberto ;
Verdonck, Leo ;
Kroeger, Nicholas ;
Niederwieser, Dietger .
BRITISH JOURNAL OF HAEMATOLOGY, 2009, 146 (06) :627-636
[6]   Conditioning with targeted busulfan and cyclophosphamide for hemopoietic stem cell transplantation from related and unrelated donors in patients with myelodysplastic syndrome [J].
Deeg, HJ ;
Storer, B ;
Slattery, JT ;
Anasetti, C ;
Doney, KC ;
Hansen, JA ;
Kiem, HP ;
Martin, PJ ;
Petersdorf, E ;
Radich, JP ;
Sanders, JE ;
Shulman, HM ;
Warren, EH ;
Witherspoon, RP ;
Bryant, EM ;
Chauncey, TR ;
Getzendaner, L ;
Storb, R ;
Appelbaum, FR .
BLOOD, 2002, 100 (04) :1201-1207
[7]   Clinical relevance of extra-hematologic comorbidity in the management of patients with myelodysplastic syndrome [J].
Della Porta, Matteo Giovanni ;
Malcovati, Luca .
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 (05) :602-606
[8]   Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study [J].
Fenaux, Pierre ;
Mufti, Ghulam J. ;
Hellstrom-Lindberg, Eva ;
Santini, Valeria ;
Finelli, Carlo ;
Giagounidis, Aristoteles ;
Schoch, Robert ;
Gattermann, Norbert ;
Sanz, Guillermo ;
List, Alan ;
Gore, Steven D. ;
Seymour, John F. ;
Bennett, John M. ;
Byrd, John ;
Backstrom, Jay ;
Zimmerman, Linda ;
McKenzie, David ;
Beach, C. L. ;
Silverman, Lewis R. .
LANCET ONCOLOGY, 2009, 10 (03) :223-232
[9]   A prognostic score for patients with lower risk myelodysplastic syndrome [J].
Garcia-Manero, G. ;
Shan, J. ;
Faderl, S. ;
Cortes, J. ;
Ravandi, F. ;
Borthakur, G. ;
Wierda, W. G. ;
Pierce, S. ;
Estey, E. ;
Liu, J. ;
Huang, X. ;
Kantarjian, H. .
LEUKEMIA, 2008, 22 (03) :538-543
[10]   New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes:: evidence from a core dataset of 2124 patients [J].
Haase, Detlef ;
Germing, Ulrich ;
Schanz, Julie ;
Pfeilstoecker, Michael ;
Noesslinger, Thomas ;
Hildebrandt, Barbara ;
Kundgen, Andrea ;
Luebbert, Michael ;
Kunzmann, Regina ;
Giagounidis, Aristoteles A. N. ;
Aul, Carlo ;
Truemper, Lorenz ;
Krieger, Otto ;
Stauder, Reinhard ;
Mueller, Thomas H. ;
Wimazal, Friedrich ;
Valent, Peter ;
Fonatsch, Christa ;
Steidl, Christian .
BLOOD, 2007, 110 (13) :4385-4395